US Stock MarketDetailed Quotes

SCPS Scopus BioPharma

Watchlist
  • 0.000400
  • 0.0000000.00%
15min DelayClose Oct 31 16:00 ET
16.83KMarket Cap-1P/E (TTM)

Scopus BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-11.77%2.93M
-42.51%2.68M
-57.61%11.71M
-71.84%1.84M
-31.21%1.9M
-78.28%3.32M
51.65%4.66M
172.11%27.63M
812.84%6.52M
215.24%2.76M
Selling and administrative expenses
-64.95%935.86K
-75.05%1.07M
-28.37%9.03M
-82.92%1.09M
-63.41%981.34K
54.61%2.67M
135.96%4.29M
361.60%12.61M
890.18%6.38M
232.77%2.68M
-General and administrative expense
-64.95%935.86K
-75.05%1.07M
-28.37%9.03M
-82.92%1.09M
-63.41%981.34K
54.61%2.67M
135.96%4.29M
361.60%12.61M
890.18%6.38M
232.77%2.68M
Research and development costs
206.87%1.99M
335.89%1.61M
-82.15%2.68M
449.29%745.9K
1,083.16%917.27K
-95.21%649.47K
-70.58%369.11K
102.37%15.02M
95.41%135.79K
11.68%77.53K
Operating profit
11.77%-2.93M
42.51%-2.68M
57.61%-11.71M
71.84%-1.84M
31.21%-1.9M
78.28%-3.32M
-51.65%-4.66M
-172.11%-27.63M
-812.84%-6.52M
-215.24%-2.76M
Net non-operating interest income expense
0
0
0
-9.66%-774.68K
0
61.10%-110.67K
Non-operating interest expense
----
----
--0
--0
--0
----
----
9.66%774.68K
--0
-61.10%110.67K
Other net income (expense)
1.46M
0
1.47M
Gain on sale of security
----
----
----
----
----
----
----
--1.46M
--0
--1.47M
Income before tax
11.77%-2.93M
42.51%-2.68M
56.54%-11.71M
71.84%-1.84M
-35.58%-1.9M
78.76%-3.32M
-36.87%-4.66M
-148.14%-26.95M
-520.31%-6.52M
-20.72%-1.4M
Income tax
Net income
11.77%-2.93M
42.51%-2.68M
56.54%-11.71M
71.84%-1.84M
-35.58%-1.9M
78.76%-3.32M
-36.87%-4.66M
-148.14%-26.95M
-520.31%-6.52M
-20.72%-1.4M
Net income continuous Operations
11.77%-2.93M
42.51%-2.68M
56.54%-11.71M
71.84%-1.84M
-35.58%-1.9M
78.76%-3.32M
-36.87%-4.66M
-148.14%-26.95M
-520.31%-6.52M
-20.72%-1.4M
Minority interest income
-312.31K
-229.83K
-105.05K
0
0
0
Net income attributable to the parent company
21.18%-2.62M
47.44%-2.45M
56.93%-11.61M
73.45%-1.73M
-35.58%-1.9M
78.76%-3.32M
-36.87%-4.66M
-148.14%-26.95M
-520.31%-6.52M
-20.72%-1.4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
21.18%-2.62M
47.44%-2.45M
56.93%-11.61M
73.45%-1.73M
-35.58%-1.9M
78.76%-3.32M
-36.87%-4.66M
-148.14%-26.95M
-520.31%-6.52M
-20.72%-1.4M
Basic earnings per share
56.25%-0.07
63.64%-0.08
64.74%-0.55
75.76%-0.08
-12.50%-0.09
83.51%-0.16
0.00%-0.22
-92.59%-1.56
-357.75%-0.33
-3.28%-0.08
Diluted earnings per share
56.25%-0.07
63.64%-0.08
64.74%-0.55
75.76%-0.08
-12.50%-0.09
83.51%-0.16
0.00%-0.22
-92.59%-1.56
-357.75%-0.33
-3.28%-0.08
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -11.77%2.93M-42.51%2.68M-57.61%11.71M-71.84%1.84M-31.21%1.9M-78.28%3.32M51.65%4.66M172.11%27.63M812.84%6.52M215.24%2.76M
Selling and administrative expenses -64.95%935.86K-75.05%1.07M-28.37%9.03M-82.92%1.09M-63.41%981.34K54.61%2.67M135.96%4.29M361.60%12.61M890.18%6.38M232.77%2.68M
-General and administrative expense -64.95%935.86K-75.05%1.07M-28.37%9.03M-82.92%1.09M-63.41%981.34K54.61%2.67M135.96%4.29M361.60%12.61M890.18%6.38M232.77%2.68M
Research and development costs 206.87%1.99M335.89%1.61M-82.15%2.68M449.29%745.9K1,083.16%917.27K-95.21%649.47K-70.58%369.11K102.37%15.02M95.41%135.79K11.68%77.53K
Operating profit 11.77%-2.93M42.51%-2.68M57.61%-11.71M71.84%-1.84M31.21%-1.9M78.28%-3.32M-51.65%-4.66M-172.11%-27.63M-812.84%-6.52M-215.24%-2.76M
Net non-operating interest income expense 000-9.66%-774.68K061.10%-110.67K
Non-operating interest expense ----------0--0--0--------9.66%774.68K--0-61.10%110.67K
Other net income (expense) 1.46M01.47M
Gain on sale of security ------------------------------1.46M--0--1.47M
Income before tax 11.77%-2.93M42.51%-2.68M56.54%-11.71M71.84%-1.84M-35.58%-1.9M78.76%-3.32M-36.87%-4.66M-148.14%-26.95M-520.31%-6.52M-20.72%-1.4M
Income tax
Net income 11.77%-2.93M42.51%-2.68M56.54%-11.71M71.84%-1.84M-35.58%-1.9M78.76%-3.32M-36.87%-4.66M-148.14%-26.95M-520.31%-6.52M-20.72%-1.4M
Net income continuous Operations 11.77%-2.93M42.51%-2.68M56.54%-11.71M71.84%-1.84M-35.58%-1.9M78.76%-3.32M-36.87%-4.66M-148.14%-26.95M-520.31%-6.52M-20.72%-1.4M
Minority interest income -312.31K-229.83K-105.05K000
Net income attributable to the parent company 21.18%-2.62M47.44%-2.45M56.93%-11.61M73.45%-1.73M-35.58%-1.9M78.76%-3.32M-36.87%-4.66M-148.14%-26.95M-520.31%-6.52M-20.72%-1.4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 21.18%-2.62M47.44%-2.45M56.93%-11.61M73.45%-1.73M-35.58%-1.9M78.76%-3.32M-36.87%-4.66M-148.14%-26.95M-520.31%-6.52M-20.72%-1.4M
Basic earnings per share 56.25%-0.0763.64%-0.0864.74%-0.5575.76%-0.08-12.50%-0.0983.51%-0.160.00%-0.22-92.59%-1.56-357.75%-0.33-3.28%-0.08
Diluted earnings per share 56.25%-0.0763.64%-0.0864.74%-0.5575.76%-0.08-12.50%-0.0983.51%-0.160.00%-0.22-92.59%-1.56-357.75%-0.33-3.28%-0.08
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data